January 27th 2023
The week's most-clicked COVID-19 stories included vaccine updates, new variants, and a pivotal FDA advisory committee vote.
Large New Zealand Study Confirms Safety Profile of Pfizer-BioNTech Vaccine
January 26th 2023The Pfizer-BioNTech COVID-19 vaccine was associated with rare instances of myo/pericarditis and acute kidney injury, according to a nationwide study in New Zealand that confirmed the safety profile of the vaccine.
Read More
PREP Act Set to Sunset in 2024 Affecting Half of US States
January 18th 2023This act designed to allow pharmacists and technicians the ability to administer certain vaccines without a prescriber order will lapse next year. A new report looks at vaccination trends in the US and how pharmacists are playing a vital role in administering vaccines.
Read More
Bivalent COVID-19 Booster Vaccination for Children Still Recommended After Safety Review
January 16th 2023A CDC report looked at 2 vaccine safety surveillance systems for the bivalent boosters in this population and there were no reports of myocarditis or death. Many of the reports were due to vaccine errors and not adverse events.
Read More
Addressing the Decline in the Number of Infectious Disease Physicians
January 12th 2023Recent numbers show a lack of new people entering the field combined with existing shortfalls in many US locations.These factors demonstrate a potentially dangerous reduction in this vital medical specialty.
Read More